Deborah Cohan, MPH, MD

Obstetrician and gynecologist

Dr. Deborah Cohan is an obstetrician and gynecologist who specializes in caring for women with HIV and reproductive infectious diseases. She also teaches body awareness and mindfulness as a way to help patients cope with illness and other life challenges. Cohan is the medical director of HIVE, a multi-disciplinary center at San Francisco General Hospital that provides reproductive and sexual wellness services for women and couples living with HIV.

Cohan's research interests include perinatal HIV transmission, prenatal HIV testing and reproductive infectious diseases. She is the founding director of the Foundation for Embodied Medicine, through which she offers training in body awareness, conscious dance and embodied presence to patients, caregivers and medical providers.

Cohan received a medical degree from Harvard Medical School, followed by a residency in obstetrics and gynecology at UCSF. She then completed a fellowship in reproductive infectious diseases at San Francisco General Hospital. Cohan also earned a master's degree in public health from University of California, Berkeley.

Cohan is a professor of obstetrics, gynecology and reproductive sciences and of family and community medicine at UCSF.

Clinics

HIV/AIDS Program
350 Parnassus Avenue, Suite 908
San Francisco, CA 94143
Phone: (415) 353-2119
Fax: (415) 353-2406

Hours: Monday to Thursday
8:30 a.m. – noon, 1 – 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Deborah Cohan

Additional Languages

Spanish

Education

Harvard School of Medicine 1996
University of California, Berkeley, Masters in Public Health 2002

Residencies

UCSF Medical Center, Obstetrics and Gynecology 2000

Fellowships

UCSF/Zuckerberg San Francisco General Hospital, Reproductive Infectious Diseases 2002

Selected Research and Publications

  1. McDonald CR, Conroy AL, Gamble JL, Papp E, Hawkes M, Olwoch P, Natureeba P, Kamya M, Silverman M, Cohan D, Koss CA, Dorsey G, Kain KC, Serghides L. Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy. Clin Infect Dis. 2018 Jan 18; 66(3):428-436.
  2. Conroy AL, McDonald CR, Gamble JL, Olwoch P, Natureeba P, Cohan D, Kamya MR, Havlir DV, Dorsey G, Kain KC. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017 12; 217(6):684.e1-684.e17.
  3. Roh ME, Shiboski S, Natureeba P, Kakuru A, Muhindo M, Ochieng T, Plenty A, Koss CA, Clark TD, Awori P, Nakalambe M, Cohan D, Jagannathan P, Gosling R, Havlir DV, Kamya MR, Dorsey G. Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis. J Infect Dis. 2017 Oct 06.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.